Jonathan Goldman - Director at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AVTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan Goldman - trading volume in the past year for Avalo Therapeutics, Inc.

Holdings reported by Jonathan Goldman for Avalo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 6.33K $53.6K $8.46 Mar 28, 2025 Direct Common Stock
Common Stock 0 $0 $14.35 Nov 14, 2025 Direct
Stock Option (Right to Buy) 16.4K Nov 14, 2025 Direct Common Stock

Transactions reported by Jonathan Goldman for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.